Oncolytics Biotech (ONCY) Jumps: Stock Rises 5% - Tale of the Tape - Alkermes (NASDAQ:ALKS)

Oncolytics Biotech Inc. ONCY was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.64 to $1.76 since March 6.

The company has seen two positive revisions in the past 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Oncolytics Biotech. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.

Oncolytics Biotech currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, some better-ranked medical stocks include Alkermes plc ALKS, Alexion Pharmaceuticals, Inc. ALXN and ANI Pharmaceuticals, Inc. ANIP. All of these sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALKERMES INC ALKS: Free Stock Analysis Report

ALEXION PHARMA ALXN: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

ONCOLYTICS BIO ONCY: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs